Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 328 (109th)

Pharmaceutical Market Access Act of 2005

openUnited States· United States Congress· EN

Introduced

25 January 2005

Last action

21 June 2005 · Introduced

Status

Sponsor introductory remarks on measure. (CR H4861)

Sponsors

Rep. Gutknecht, Gil [R-MN-1], Rep. Emanuel, Rahm [D-IL-5], Rep. Emerson, Jo Ann [R-MO-8], Sen. Sanders, Bernard [I-VT], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Northup, Anne M. [R-KY-3], Rep. Burton, Dan [R-IN-5], Rep. Brown-Waite, Ginny [R-FL-5], Rep. Jones, Walter B., Jr. [R-NC-3], Sen. Brown, Sherrod [D-OH], Rep. Istook, Ernest J., Jr. [R-OK-5], Rep. Kingston, Jack [R-GA-1], Rep. Ramstad, Jim [R-MN-3], Rep. King, Steve [R-IA-4], Rep. Langevin, James R. [D-RI-2], Rep. Hoekstra, Peter [R-MI-2], Rep. Berry, Marion [D-AR-1], Rep. Hensarling, Jeb [R-TX-5], Sen. Van Hollen, Chris [D-MD], Rep. Simpson, Michael K. [R-ID-2], Rep. Otter, C. L. (Butch) [R-ID-1], Rep. Herseth Sandlin, Stephanie [D-SD-At Large], Rep. Berkley, Shelley [D-NV-1], Rep. Pallone, Frank [D-NJ-6], Rep. Petri, Thomas E. [R-WI-6], Rep. Tancredo, Thomas G. [R-CO-6], Rep. Case, Ed [D-HI-1], Rep. Meehan, Martin T. [D-MA-5], Rep. Holden, Tim [D-PA-17], Rep. McDermott, Jim [D-WA-7], Rep. Delahunt, William D. [D-MA-10], Rep. Owens, Major R. [D-NY-11], Rep. Frank, Barney [D-MA-4], Rep. Renzi, Rick [R-AZ-1], Rep. McGovern, James P. [D-MA-2], Rep. McNulty, Michael R. [D-NY-23], Rep. McCarthy, Carolyn [D-NY-4], Rep. Olver, John W. [D-MA-1], Sen. Flake, Jeff [R-AZ], Rep. Bass, Charles F. [R-NH-2], Rep. Carnahan, Russ [D-MO-3], Rep. Kanjorski, Paul E. [D-PA-11], Rep. Butterfield, G. K. [D-NC-1], Rep. Hastings, Doc [R-WA-4], Rep. Wolf, Frank R. [R-VA-10], Rep. Cooper, Jim [D-TN-5], Rep. Abercrombie, Neil [D-HI-1], Rep. Musgrave, Marilyn N. [R-CO-4]

Subjects

Healthcare

Source updated

10 January 2026

Healthcare

Summary

Pharmaceutical Market Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to promulgate regulations permitting pharmacists, pharmacies, wholesalers, and individuals to import qualifying drugs from certain countries into the United States. Sets forth registration requirements for exporters. Requires the Secretary to: (1) educate consumers with regard to the availability of qualifying drugs for import for personal use; (2) inspect the facilities and records of importers and registered exporters to ensure compliance with this Act; and (3) establish a registration fee program to collect an annual fee from registered exporters. Deems a prescription drug to be misbranded unless the packaging of such drug complies with the requirements for counterfeit-resistant technologies. Prohibits: (1) failing to register in accordance with this Act; and (2) importing or offering to import a prescription drug in violation of a suspension order. Declares that selling or importing a patented drug in the United States that was first sold abroad by or under authority of the owner or licensee of the patent is not patent infringement. Prohibits drug manufacturers from discriminating against a person that engages in the importation of a prescription drug, including by charging higher prices or denying supplies of the drug. Allows the Secretary to suspend or terminate the registration of an exporter for failing to maintain substantial compliance with all registration conditions.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 January 2005

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 25 January 2005

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 25 January 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 25 January 2005

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 15 February 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H606)

    Source: IntroReferral

  6. 25 February 2005

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  7. 2 March 2005

    Referred

    Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

    Source: Committee

  8. 5 April 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H1754)

    Source: IntroReferral

  9. 13 April 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H1945-1946)

    Source: IntroReferral

  10. 16 May 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H3289-3290)

    Source: IntroReferral

  11. 17 May 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H3406-3407)

    Source: IntroReferral

  12. 20 June 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H4784-4785)

    Source: IntroReferral

  13. 21 June 2005

    Introduced

    Sponsor introductory remarks on measure. (CR H4861)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 25 January 2005

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 25 January 2005

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 25 January 2005

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 124 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.